Title of article - Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention.
Abstract
To study the effect of bivalirudin plus loading dose of cilostazol-based triple-antiplatelet therapy strategy in patients undergoing percutaneous coronary intervention (PCI).
CLICK HERE for Full article Click button above to go to original article link with complete article details for Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention.
Please CLICK HERE to discuss with us on facebook about this article.
Click below for Details of research Institute
Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Details of Journal for Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention.
Journal Title - Therapeutics and clinical risk management
ISSN - 1176-6336
Volume - 11
Issue - 0
Publish date - 2015-
Language - eng
Country - New Zealand
No comments:
Post a Comment